IPCALAB

Ipca Laboratories Share Price

₹1,525.90 -19.9 (-1.29%)

22 Jan, 2025 12:32

SIP TrendupStart SIP in IPCALAB

Start SIP

Performance

  • Low
  • ₹1,521
  • High
  • ₹1,560
  • 52 Week Low
  • ₹1,052
  • 52 Week High
  • ₹1,756
  • Open Price₹1,547
  • Previous Close₹1,546
  • Volume87,468

Investment Returns

  • Over 1 Month -3.58%
  • Over 3 Month -5.48%
  • Over 6 Month + 27.82%
  • Over 1 Year + 41.59%
SIP Lightning

Smart Investing Starts Here Start SIP with Ipca Laboratories for Steady Growth!

Invest Now

Ipca Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 58.6
  • PEG Ratio
  • 1.7
  • Market Cap Cr
  • 38,713
  • P/B Ratio
  • 5.8
  • Average True Range
  • 45.35
  • EPS
  • 26.47
  • Dividend Yield
  • 0.3
  • MACD Signal
  • 7.29
  • RSI
  • 39.45
  • MFI
  • 44.62

Ipca Laboratories Financials

Ipca Laboratories Technicals

EMA & SMA

Current Price
₹1,525.90
-19.9 (-1.29%)
pointer
  • stock-down_img
  • Bearish Moving Average 13
  • stock-up_img
  • Bullish Moving Average 3
  • 20 Day
  • ₹1,601.73
  • 50 Day
  • ₹1,587.37
  • 100 Day
  • ₹1,534.17
  • 200 Day
  • ₹1,426.93

Resistance and Support

1555.17 Pivot Speed
  • R3 1,616.78
  • R2 1,599.37
  • R1 1,572.58
  • S1 1,528.38
  • S2 1,510.97
  • S3 1,484.18

What's your outlook on Ipca Laboratories?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Ipca Laboratories Ltd. is a global pharmaceutical company, producing over 350 formulations and 80 APIs. Operating in 120+ countries, it leads in therapeutic areas like pain, rheumatology, and antimalarials, with fully-automated facilities approved by global regulatory bodies.

Ipca Laboratories has an operating revenue of Rs. 8,533.40 Cr. on a trailing 12-month basis. An annual revenue growth of 23% is outstanding, Pre-tax margin of 11% is healthy, ROE of 8% is fair but needs improvement. The company has a reasonable debt to equity of 9%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 9% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It has recently broken out of a base in its weekly chart but failed to keep its momentum and is trading around -9% from the pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 68 which is a FAIR score but needs to improve its earnings, a RS Rating of 66 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 55 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Overall, the stock definitely has some strength, you may want to examine it in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Ipca Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-14 Quarterly Results & Interim Dividend
2024-09-30 Others
2024-08-13 Quarterly Results
2024-05-29 Audited Results & Final Dividend
2024-02-14 Quarterly Results
Date Purpose Remarks
2024-11-25 INTERIM Rs.2.00 per share(200%)Interim Dividend (Revised)
2023-11-22 INTERIM Rs.2.00 per share(200%)Interim Dividend (Revised)
2022-11-23 INTERIM Rs.4.00 per share(400%)Interim Dividend
2021-11-23 INTERIM Rs.8.00 per share(400%)Interim Dividend
View More
Date Purpose Remarks
2022-01-11 Split Rs.0.00 split from Rs. 2/- to Re. 1/-.

Ipca Laboratories F&O

Ipca Laboratories Shareholding Pattern

44.72%
29.63%
5.19%
11.06%
0%
6.88%
2.52%

About Ipca Laboratories

  • NSE Symbol
  • IPCALAB
  • BSE Symbol
  • 524494
  • Managing Director
  • Mr. Ajit Kumar Jain
  • ISIN
  • INE571A01038

Similar Stocks to Ipca Laboratories

Ipca Laboratories FAQs

Ipca Laboratories share price is ₹1,525 As on 22 January, 2025 | 12:18

The Market Cap of Ipca Laboratories is ₹38712.7 Cr As on 22 January, 2025 | 12:18

The P/E ratio of Ipca Laboratories is 58.6 As on 22 January, 2025 | 12:18

The PB ratio of Ipca Laboratories is 5.8 As on 22 January, 2025 | 12:18

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23